These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism. Reiffel JA; Camm AJ; Belardinelli L; Zeng D; Karwatowska-Prokopczuk E; Olmsted A; Zareba W; Rosero S; Kowey P; Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1048-56. PubMed ID: 26226999 [TBL] [Abstract][Full Text] [Related]
27. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH; Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319 [TBL] [Abstract][Full Text] [Related]
28. Impact of dronedarone in atrial fibrillation and flutter on stroke reduction. Christiansen CB; Torp-Pedersen C; Køber L Clin Interv Aging; 2010 Apr; 5():63-9. PubMed ID: 20396635 [TBL] [Abstract][Full Text] [Related]
29. Dronedarone: an emerging therapy for atrial fibrillation. Rosei EA; Salvetti M Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of dronedarone in the treatment of patients with atrial fibrillation. Khan MH; Rochlani Y; Aronow WS Expert Opin Drug Saf; 2017 Dec; 16(12):1407-1412. PubMed ID: 28960089 [TBL] [Abstract][Full Text] [Related]
31. Dronedarone: an emerging agent with rhythm- and rate-controlling effects. Wegener FT; Ehrlich JR; Hohnloser SH J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434 [TBL] [Abstract][Full Text] [Related]
32. Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics. Wu C; Tcherny-Lessenot S; Dai W; Wang Y; Kechemir H; Gandhi S; Lin S; Juhaeri J Clin Ther; 2018 Mar; 40(3):450-455.e1. PubMed ID: 29500139 [TBL] [Abstract][Full Text] [Related]
33. Effects of dronedarone on all-cause mortality and on cardiovascular events in patients treated for atrial fibrillation: a meta-analysis of RCTs. De Vecchis R; Ariano C Minerva Cardioangiol; 2019 Apr; 67(2):163-171. PubMed ID: 30260141 [TBL] [Abstract][Full Text] [Related]
34. [Amiodarone: treatment or cause of atrial fibrillation?]. Allali G; Falconnet C Rev Med Suisse; 2005 Nov; 1(39):2533-5. PubMed ID: 16323735 [TBL] [Abstract][Full Text] [Related]
35. Case Report: Presumed Optic Neuropathy after Amiodarone and then Dronedarone for Treatment of Atrial Fibrillation. Maharshak I; Paul M; Steiner H Optom Vis Sci; 2020 Aug; 97(8):561-564. PubMed ID: 32833401 [TBL] [Abstract][Full Text] [Related]
36. Amiodarone and dronedarone: An update. Vamos M; Hohnloser SH Trends Cardiovasc Med; 2016 Oct; 26(7):597-602. PubMed ID: 27155812 [TBL] [Abstract][Full Text] [Related]
37. Dronedarone: an overview. Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093 [TBL] [Abstract][Full Text] [Related]
38. Dronedarone for the management of atrial fibrillation. Brenner R; Delacrétaz E Swiss Med Wkly; 2011; 141():w13158. PubMed ID: 21370206 [TBL] [Abstract][Full Text] [Related]
39. [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131]. Hermida JS; Jarry G; Tcheng E; Moullart V; Arlot S; Rey JL; Schvartz C Arch Mal Coeur Vaiss; 2004 Mar; 97(3):207-13. PubMed ID: 15106744 [TBL] [Abstract][Full Text] [Related]
40. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Dale KM; White CM Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]